Fox Chase Cancer Center News

PHILADELPHIA (October 26, 2020)—Researchers from Fox Chase Cancer Center have presented new data that shows that moderately hypofractionated photon and proton therapies are both safe for patients with low- or intermediate-risk prostate cancer.

PHILADELPHIA (October 23, 2020) – Researchers at Fox Chase Cancer Center have discovered a potential new target in the treatment of endometrial carcinoma, thanks in part to generous funding from Peggy’s Pathway for Women’s Cancer Care. The research was published recently in Molecular & Cellular Proteomics.

PHILADELPHIA (October 23, 2020)— Carolyn Y. Fang, PhD, professor and co-leader of the Cancer Prevention and Control Program at Fox Chase Cancer Center, has been promoted to the role of associate director for Population Science.

PHILADELPHIA (October 22, 2020)—Erica Golemis, PhD, deputy chief science officer and co-leader of the Molecular Therapeutics research program at Fox Chase Cancer Center, was recently appointed senior editor at eLife, an open-access, peer-reviewed journal.

PHILADELPHIA (October 13, 2020)—Fox Chase Cancer Center has unveiled a new micro-ultrasound system that physicians say could change the way prostate cancer is diagnosed.

PHILADELPHIA (October 19, 2020)—Philadelphia magazine has named 72 Temple and Fox Chase Cancer Center physicians to its “Top Doctors in Cancer Care” list for 2020. Physicians on the list were nominated by their professional peers.

PHILADELPHIA (October 16, 2020)—Fox Chase Cancer Center presented its signature fundraising event, In Vino Vita, on Friday, October 2, 2020. The seventh annual event was held virtually for the first time this year and raised over $700,000 for cancer research at Fox Chase.

PHILADELPHIA (October 14, 2020)—Fox Chase Cancer Center has been selected as the newest institution in The Melanoma Research Foundation Breakthrough Consortium (MRFBC).